STOCK TITAN

Incyte to Report First Quarter Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Incyte (NASDAQ:INCY) has announced its conference call and webcast scheduled for May 2, 2023, at 8:00 a.m. ET to discuss its Q1 2023 financial results. The press release for these results will be available earlier that day at 7:00 a.m. ET. Investors can access the call via domestic and international dial-in numbers or through an online webcast at Investor.Incyte.com. A replay of the conference call will be accessible for 30 days following the event. Incyte is a global biopharmaceutical company headquartered in Wilmington, Delaware, dedicated to addressing serious unmet medical needs through the development of innovative therapeutics.

Positive
  • None.
Negative
  • None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, May 2, 2023.

  • The schedule for the press release and conference call/webcast is as follows:
  • Q1 2023 Press Release: May 2, 2023 at 7:00 a.m. ET
  • Q1 2023 Conference Call: May 2, 2023 at 8:00 a.m. ET
  • Domestic Dial-In Number: 877-407-3042
  • International Dial-In Number: 201-389-0864
  • Conference ID Number: 13737924

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13737924.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.com

Investors

Christine Chiou

+1 302 274 4773

cchiou@incyte.com

Source: Incyte

FAQ

When will Incyte announce its Q1 2023 financial results?

Incyte will announce its Q1 2023 financial results on May 2, 2023, at 7:00 a.m. ET.

What time is the Incyte Q1 2023 conference call?

The conference call for Incyte's Q1 2023 results is scheduled for May 2, 2023, at 8:00 a.m. ET.

How can I access the Incyte conference call?

You can access the Incyte conference call via domestic dial-in number 877-407-3042 or international dial-in number 201-389-0864, using conference ID 13737924.

Will there be a replay of the Incyte conference call?

Yes, a replay of the conference call will be available for 30 days after the event.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.56B
188.30M
2.04%
97.86%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON